Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Cell Cycle (Georgetown, Tex.)
|
October 20, 2004
The importance of genome architecture in cancer susceptibility: location, location, location
Karlyne M Reilly
Brain Pathology (Zurich, Switzerland)
|
December 17, 2008
Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk
Karlyne M Reilly
Cancer Discovery
|
June 11, 2013
Extending the convergence of canonical WNT signaling and classic cancer pathways for treatment of malignant peripheral nerve sheath tumors
Karlyne M Reilly
Cold Spring Harbor Protocols
|
March 3, 2016
Controlling Genetic Background in Crosses of Mouse Models of Cancer
Karlyne M Reilly
Cold Spring Harbor Protocols
|
March 3, 2016
Using the Collaborative Cross to Study the Role of Genetic Diversity in Cancer-Related Phenotypes
Karlyne M Reilly
EMBO Molecular Medicine
|
January 6, 2010
Neurofibromatosis and lessons for the war on cancer
Karlyne M Reilly
Cold Spring Harbor Protocols
|
March 3, 2016
The Effects of Genetic Background of Mouse Models of Cancer: Friend or Foe?
Karlyne M Reilly
CNS Oncology
|
December 22, 2016
The role of the immune system in neurofibromatosis type 1-associated nervous system tumors
Souvik Karmakar, Karlyne M Reilly
Toxicologic Pathology
|
February 24, 2010
Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis
Jessica J Hawes, Karlyne M Reilly
Cell
|
November 6, 2008
It takes a (dysfunctional) village to raise a tumor
Karlyne M Reilly, Terry Van Dyke
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Cell Cycle (Georgetown, Tex.)
|
October 20, 2004
The importance of genome architecture in cancer susceptibility: location, location, location
Karlyne M Reilly
Brain Pathology (Zurich, Switzerland)
|
December 17, 2008
Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk
Karlyne M Reilly
Cancer Discovery
|
June 11, 2013
Extending the convergence of canonical WNT signaling and classic cancer pathways for treatment of malignant peripheral nerve sheath tumors
Karlyne M Reilly
Cold Spring Harbor Protocols
|
March 3, 2016
Controlling Genetic Background in Crosses of Mouse Models of Cancer
Karlyne M Reilly
Cold Spring Harbor Protocols
|
March 3, 2016
Using the Collaborative Cross to Study the Role of Genetic Diversity in Cancer-Related Phenotypes
Karlyne M Reilly
EMBO Molecular Medicine
|
January 6, 2010
Neurofibromatosis and lessons for the war on cancer
Karlyne M Reilly
Cold Spring Harbor Protocols
|
March 3, 2016
The Effects of Genetic Background of Mouse Models of Cancer: Friend or Foe?
Karlyne M Reilly
CNS Oncology
|
December 22, 2016
The role of the immune system in neurofibromatosis type 1-associated nervous system tumors
Souvik Karmakar, Karlyne M Reilly
Toxicologic Pathology
|
February 24, 2010
Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis
Jessica J Hawes, Karlyne M Reilly
Cell
|
November 6, 2008
It takes a (dysfunctional) village to raise a tumor
Karlyne M Reilly, Terry Van Dyke
Page
of 6